Our pre-specified analysis of the five endo-lysosomal proteins most likely to show relevant HD-related alterations (Cathepsin D, Cathepsin F, GM2A, LAMP1 and LAMP2) found no discernible differences in concentration between HD mutation carriers and controls. The gene discussed is GM2A; the disease is Huntington disease.